These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 31418556)

  • 1. Design and Biological Evaluation of Lipoprotein-Based Donepezil Nanocarrier for Enhanced Brain Uptake through Oral Delivery.
    Krishna KV; Wadhwa G; Alexander A; Kanojia N; Saha RN; Kukreti R; Singhvi G; Dubey SK
    ACS Chem Neurosci; 2019 Sep; 10(9):4124-4135. PubMed ID: 31418556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biophysical, Biochemical, and Behavioral Implications of ApoE3 Conjugated Donepezil Nanomedicine in a Aβ
    Krishna KV; Saha RN; Dubey SK
    ACS Chem Neurosci; 2020 Dec; 11(24):4139-4151. PubMed ID: 33251785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donepezil-Loaded Nanocarriers for the Treatment of Alzheimer's Disease: Superior Efficacy of Extracellular Vesicles Over Polymeric Nanoparticles.
    Oliveira Silva R; Counil H; Rabanel JM; Haddad M; Zaouter C; Ben Khedher MR; Patten SA; Ramassamy C
    Int J Nanomedicine; 2024; 19():1077-1096. PubMed ID: 38317848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donepezil loaded PLGA-b-PEG nanoparticles: their ability to induce destabilization of amyloid fibrils and to cross blood brain barrier in vitro.
    Baysal I; Ucar G; Gultekinoglu M; Ulubayram K; Yabanoglu-Ciftci S
    J Neural Transm (Vienna); 2017 Jan; 124(1):33-45. PubMed ID: 26911385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral delivery of indinavir using mPEG-PCL nanoparticles: preparation, optimization, cellular uptake, transport and pharmacokinetic evaluation.
    Kurd M; Sadegh Malvajerd S; Rezaee S; Hamidi M; Derakhshandeh K
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2123-2133. PubMed ID: 31155961
    [No Abstract]   [Full Text] [Related]  

  • 6. Reassembly of native components with donepezil to execute dual-missions in Alzheimer's disease therapy.
    Zhang H; Zhao Y; Yu M; Zhao Z; Liu P; Cheng H; Ji Y; Jin Y; Sun B; Zhou J; Ding Y
    J Control Release; 2019 Feb; 296():14-28. PubMed ID: 30639387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation, characterization, in vivo biodistribution and pharmacokinetic studies of donepezil-loaded PLGA nanoparticles for brain targeting.
    Md S; Ali M; Baboota S; Sahni JK; Bhatnagar A; Ali J
    Drug Dev Ind Pharm; 2014 Feb; 40(2):278-87. PubMed ID: 23369094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nose-to-Brain Targeted Delivery of Donepezil Hydrochloride via Novel Hyaluronic Acid-Doped Nanotransfersomes for Alzheimer's Disease Mitigation.
    Salem HF; Aboud HM; Abdellatif MM; Abou-Taleb HA
    J Pharm Sci; 2024 Jul; 113(7):1934-1945. PubMed ID: 38369023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ApoE3 Anchored Liposomal Delivery of Rivastigmine for Brain Delivery: Formulation, Characterization, and In Vivo Pharmacokinetic Evaluation.
    Khairnar P; Singh A; Ahirwar K; Shukla R
    AAPS PharmSciTech; 2023 Nov; 24(8):223. PubMed ID: 37945928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inorganic clay nanocomposite system for improved cholinesterase inhibition and brain pharmacokinetics of donepezil.
    Singh AK; Mishra SK; Mishra G; Maurya A; Awasthi R; Yadav MK; Atri N; Pandey PK; Singh SK
    Drug Dev Ind Pharm; 2020 Jan; 46(1):8-19. PubMed ID: 31809608
    [No Abstract]   [Full Text] [Related]  

  • 11. A Systematic Review on Donepezil-based Derivatives as Potential Cholinesterase Inhibitors for Alzheimer's Disease.
    Korabecny J; Spilovska K; Mezeiova E; Benek O; Juza R; Kaping D; Soukup O
    Curr Med Chem; 2019; 26(30):5625-5648. PubMed ID: 29768996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoformulated alpha-mangostin ameliorates Alzheimer's disease neuropathology by elevating LDLR expression and accelerating amyloid-beta clearance.
    Yao L; Gu X; Song Q; Wang X; Huang M; Hu M; Hou L; Kang T; Chen J; Chen H; Gao X
    J Control Release; 2016 Mar; 226():1-14. PubMed ID: 26836197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oleocanthal-rich extra-virgin olive oil enhances donepezil effect by reducing amyloid-β load and related toxicity in a mouse model of Alzheimer's disease.
    Batarseh YS; Kaddoumi A
    J Nutr Biochem; 2018 May; 55():113-123. PubMed ID: 29413486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein-based nanoparticles rescue the memory loss of mice with Alzheimer's disease by accelerating the clearance of amyloid-beta.
    Song Q; Huang M; Yao L; Wang X; Gu X; Chen J; Chen J; Huang J; Hu Q; Kang T; Rong Z; Qi H; Zheng G; Chen H; Gao X
    ACS Nano; 2014 Mar; 8(3):2345-59. PubMed ID: 24527692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 5-HT
    Skovgård K; Agerskov C; Kohlmeier KA; Herrik KF
    Neuropharmacology; 2018 Dec; 143():130-142. PubMed ID: 30243914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donepezil Derivatives Targeting Amyloid-β Cascade in Alzheimer's Disease.
    Mezeiova E; Chalupova K; Nepovimova E; Gorecki L; Prchal L; Malinak D; Kuca K; Soukup O; Korabecny J
    Curr Alzheimer Res; 2019; 16(9):772-800. PubMed ID: 30819078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs.
    Agrawal M; Saraf S; Saraf S; Antimisiaris SG; Chougule MB; Shoyele SA; Alexander A
    J Control Release; 2018 Jul; 281():139-177. PubMed ID: 29772289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and biological evaluation of Repaglinide loaded polymeric nanocarriers for diabetes linked neurodegenerative disorder: QbD-driven optimization, in situ, in vitro and in vivo investigation.
    Wadhwa G; Venkata Krishna K; Kumar Dubey S; Taliyan R
    Int J Pharm; 2023 Apr; 636():122824. PubMed ID: 36921745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donepezil attenuates Aβ-associated mitochondrial dysfunction and reduces mitochondrial Aβ accumulation in vivo and in vitro.
    Ye CY; Lei Y; Tang XC; Zhang HY
    Neuropharmacology; 2015 Aug; 95():29-36. PubMed ID: 25744714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effect of orally administered donepezil hydrochloride (E2020), a novel treatment for Alzheimer's disease, on cholinesterase activity in rats.
    Kosasa T; Kuriya Y; Matsui K; Yamanishi Y
    Eur J Pharmacol; 2000 Feb; 389(2-3):173-9. PubMed ID: 10688981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.